Forskolin reverses tachyphylaxis to the bronchodilator effects of salbutamol: An in-vitro study on isolated guinea-pig trachea

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 2, 1999, Pages 181-186

  Yousif, Mariam H ^a   Thulesius, Olav ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBACHOL; ENZYME ACTIVATOR; FORSKOLIN; SALBUTAMOL;

ANIMAL TISSUE; ARTICLE; ASTHMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG POTENTIATION; GUINEA PIG; MALE; NONHUMAN; SMOOTH MUSCLE RELAXATION; TACHYPHYLAXIS; TRACHEA;

EID: 0033000082     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772114     Document Type: Article

References (20)

1. Abramson, S. N., Molinoff, P. B. (1984) in vitro interactions of agonists and antagonists with β-adrenergic receptors. Biochem. Pharmacol. 33: 869-875
2. Adnot, S., Desmier, M., Ferry, N., Hanoune, J., Sevenet, T. (1982) Forskolin, a powerful inhibitor of human platelet aggregation. Biochem. Pharmacol. 31: 4071-4074
3. Brooker, G., Pedone, C., Barovsky, K. (1983) Selective reduction of forskolin-stimulated cyclic AMP accumulation by inhibitors of protein synthesis. Science 220: 1169-1170
4. Christenson, J. T., Thulesius, O., Owunwanne, A., Nazzal, M. (1991) Forskolin impregnation of small calibre PTFE grafts lowers early platelet graft sequestration and improves potency in a sheep model. Eur. J. Vas. Surg. 5: 271-275
5. Darfler, F., Mahan, L., Koachman, A., Insel, P. (1982) Stimulation by forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J. Biol. Chem. 257: 11901-11907
6. Harvey, J. E., Tattersfield, A. E. (1982) Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic and asthmatic subjects. Thorax 37: 280-287
7. Kreutner, W., Chapman, R., Gulbenkian, A., Tozzi, S. (1985) Bronchodilator and antiallergy activity of forskolin. Eur. J. Pharmacol. 111: 1-8
8. Larsson, K., Martinsson, A., Hjemdahl, P. (1992) Influence of β-adrenergic receptor function during terbutaline treatment on allergen sensitivity and bronchodilator response to terbutaline in asthmatic subjects. Chest 101: 953-960
9. Lefkowitz, R. J., Caron, M., Michel, T., Stadel, J. (1982) Mechanisms of hormone receptor-effector coupling: the β-adrenergic receptor and adenylate cyclase. Fed. Proc. 41: 2664
10. Litosch, I., Hudson, T., Mills, I., Li, S., Fain, J. (1982) Forskolin as an act of cyclic AMP accumulation and lipolysis in rat adipocytes. Mol. Pharmacol. 22: 109-115
11. Ljusegren, M. E., Ahlner, J., Axelsson, K. (1988) Studies on vascular smooth muscle tolerance to different cGMP-mediated vasodilators and cross-tolerance to glyceryl trinitrate. Pharmacol. Toxicol. 62: 302-307
12. Metzger, H., Lindner, E. (1981) The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneim. Forsch. 31: 1248-1250
13. Miao, F. J., Lee, T. J. (1992) Regional variation in acute vascular homologous tachyphylaxis. J. Pharmacol. Exp. Ther. 260: 644-651
14. Moriwaki, K., Itoh, Y., Iida, S., Ichihara, K. (1982) Forskolin potentiates adrenocorticotropin-induced cyclic AMP production and steroidogenesis in isolated rat adrenal cells. Life Sci. 30: 2235-2240
15. 2-adrenoceptors. Gen. Pharmacol. 28: 753-756
16. Seamon, K., Daly, J. (1981) Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7: 201-224
17. Seamon, K., Daly, J. (1986) Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotides Protein Phosphorylation Res. 20: 1-150
18. Seamon, K., Padgett, W., Daly, J. (1981) Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl Acad. Sci. USA 78: 3363-3367
19. 2 agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Safety 11: 259-283
20. Siegl, A., Daly, J., Smith, J. (1982) Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin. Mol. Pharmacol. 21: 680-687